Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
$6.37
$0.38
$1.24
$26.05M0.91522,308 shs466,373 shs
CTYX
Curative Biotechnology
$0.02
-2.8%
$0.03
$0.00
$0.22
$9.44M-33.993.01 million shs69,834 shs
Emmaus Life Sciences, Inc. stock logo
EMMA
Emmaus Life Sciences
$0.11
$0.11
$0.05
$0.33
$6.71M1.614,369 shsN/A
PFHOD
Pacific Health Care Organization
$1.25
-69.5%
$1.25
$1.11
$5.90
$16M0.941,720 shs2,100 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
0.00%0.00%0.00%0.00%0.00%
CTYX
Curative Biotechnology
0.00%-7.06%+8.70%-16.67%+32.98%
Emmaus Life Sciences, Inc. stock logo
EMMA
Emmaus Life Sciences
0.00%-4.55%0.00%+0.96%-67.19%
PFHOD
Pacific Health Care Organization
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
CTYX
Curative Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/A
Emmaus Life Sciences, Inc. stock logo
EMMA
Emmaus Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/A
CTYX
Curative Biotechnology
N/AN/AN/AN/A
Emmaus Life Sciences, Inc. stock logo
EMMA
Emmaus Life Sciences
N/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/A$1.54 per shareN/A
CTYX
Curative Biotechnology
N/AN/AN/AN/AN/AN/A
Emmaus Life Sciences, Inc. stock logo
EMMA
Emmaus Life Sciences
$18.39M0.36N/AN/A($0.69) per share-0.15
PFHOD
Pacific Health Care Organization
$6.80M2.35$0.11 per share11.21$0.63 per share1.98

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
-$27.47M-$0.41N/AN/AN/AN/A-27.24%-26.08%N/A
CTYX
Curative Biotechnology
N/AN/A0.00N/AN/AN/AN/AN/A
Emmaus Life Sciences, Inc. stock logo
EMMA
Emmaus Life Sciences
-$10.62M-$0.10N/AN/A-16.66%N/A-9.73%N/A
PFHOD
Pacific Health Care Organization
$1.36MN/A0.00N/A16.87%14.47%12.96%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/AN/A
CTYX
Curative Biotechnology
N/AN/AN/AN/AN/A
Emmaus Life Sciences, Inc. stock logo
EMMA
Emmaus Life Sciences
N/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/A
22.33
22.33
CTYX
Curative Biotechnology
N/AN/AN/A
Emmaus Life Sciences, Inc. stock logo
EMMA
Emmaus Life Sciences
N/A
0.15
0.12
PFHOD
Pacific Health Care Organization
0.05
12.91
12.91

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
2760.58 million59.25 millionOptionable
CTYX
Curative Biotechnology
N/A388.50 millionN/ANot Optionable
Emmaus Life Sciences, Inc. stock logo
EMMA
Emmaus Life Sciences
5463.87 million41.51 millionNot Optionable
PFHOD
Pacific Health Care Organization
3912.80 millionN/ANot Optionable

PFHOD, CLBS, CTYX, and EMMA Headlines

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

Company Descriptions

Caladrius Biosciences logo

Caladrius Biosciences

NASDAQ:CLBS
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Curative Biotechnology

OTCMKTS:CTYX
Curative Biotechnology, Inc. engages in the provision of software solutions for the healthcare market. Its products include MedFlash, electronic Personal Health Manager, Medical Alert, personal emergency response services, product and medical transcription, disease management, revenue cycle management, and medical consulting-billing. The company was founded by Jon Pevzner on July 29, 1995 and is headquartered in Boca Raton, FL.
Emmaus Life Sciences logo

Emmaus Life Sciences

OTCMKTS:EMMA
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. The company was founded in 2000 and is headquartered in Torrance, California.

Pacific Health Care Organization

OTCMKTS:PFHOD
Pacific Health Care Organization, Inc., together with its subsidiaries, provides specialty workers' compensation managed care services for self-administered employers, insurers, third party administrators, municipalities, and others in the United States. The company is involved in managing health care organizations (HCOs) and medical provider networks (MPNs); and negotiating legal agreements for the implementation of workers' compensation carve-outs for California clients/employers with collective bargaining units. It also offers HCO and MPN programs; medical case management services; and ancillary services, including utilization and medical bill review, lien representation, legal support, Medicare set aside, and network access services for workers' compensation claims. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Newport Beach, California.